Kasner, S. E., Swaminathan, B., Lavados, P. M., Sharma, M., Muir, K. W., Veltkamp, R., . . . Baumgartner, P. (2018). Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: A prespecified subgroup analysis from the NAVIGATE ESUS trial.
शिकागो शैली (17वां संस्करण) प्रशस्ति पत्रKasner, Scott E., et al. Rivaroxaban or Aspirin for Patent Foramen Ovale and Embolic Stroke of Undetermined Source: A Prespecified Subgroup Analysis from the NAVIGATE ESUS Trial. 2018.
एमएलए (9वां संस्करण) प्रशस्ति पत्रKasner, Scott E., et al. Rivaroxaban or Aspirin for Patent Foramen Ovale and Embolic Stroke of Undetermined Source: A Prespecified Subgroup Analysis from the NAVIGATE ESUS Trial. 2018.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.